Cite
HARVARD Citation
Nathan, S. et al. (2016). Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 71 (5), pp. 429-435. [Online].